Deepa Shetty
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Deepa Shetty has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Neelam Kapse
Bioenergy Group, MACS-Agharkar Research Institute, G.G. Agarkar Road, Pune 411004, Maharashtra, India
4 shared publications - Prashant Kamalakar Dhakephalkar
Bioenergy Group, MACS-Agharkar Research Institute, G.G. Agarkar Road, Pune 411004, Maharashtra, India
4 shared publications - Shilpa Wagh
Hi Tech BioSciences India Ltd., Research & Development Center, Plot No. 6 and 8, Ambadvet Industrial Estate, PO Paud, Pune 412108, Maharashtra, India
4 shared publications - Sumit Singh Dagar
Bioenergy Group, MACS-Agharkar Research Institute, G.G. Agarkar Road, Pune 411004, Maharashtra, India
4 shared publications - Prajakta Margale
Bioenergy Group, MACS-Agharkar Research Institute, G.G. Agarkar Road, Pune 411004, Maharashtra, India
3 shared publications - Tanisha Dhakephalkar
Hi Tech BioSciences India Ltd., Research & Development Centre, Plot No. 6 and 8, Ambadvet Industrial Estate, PO Paud, Pune 412108, Maharashtra, India
3 shared publications
Latest Publications
- Open Access
A Human-Derived Putative Probiotic, Ligilactobacillus salivarius MCC0226 with Adhesion, Antipathogenic, and Epithelial Gene-Modulatory Properties
Ligilactobacillus salivarius is a well-recognized probiotic species; however, the mechanisms by which individual strains contribute to gut ecosystem homeostasis and protection of the intestinal epithelial barrier remain poorly understood. This study comprehensively characterized a human-derived L. salivarius MCC0226 using an integrated genomic and functional approach to evaluate its probiotic potential. Whole-genome sequencing identified genes associated with acid and bile tolerance, adhesion, exopolysaccharide biosynthesis, oxidative stress response, bacteriocin production, bile salt hydrolase activity, and amino acid biosynthesis. At the same time, genomic safety analysis confirmed the absence of virulence factors and clinically relevant transferable antimicrobial resistance determinants. MCC0226 exhibited high survival under simulated gastric and intestinal conditions, produced 0.64 g L−1 exopolysaccharides, and showed strong adhesion to HT-29 and Caco-2 intestinal epithelial cells. The strain demonstrated broad-spectrum antimicrobial activity against 13 clinically relevant pathogens, reduced adhesion of Salmonella Typhimurium and Clostridioides difficile on HT-29 cells, co-aggregated with enteric pathogens, and produced hydrogen peroxide. Functional metabolite analysis revealed antioxidant activity, cholesterol assimilation under simulated intestinal and colonic conditions, positive bile salt hydrolase activity, and production of lactic, acetic, and butyric acids during inulin fermentation. Furthermore, MCC0226 significantly modulated the expression of epithelial junction-associated genes in HT-29 cells, including OCLN, CLDN3, CDH1, and CLDN2, while ZO-1 remained essentially unaffected. The combined genomic and in vitro evidence indicates that MCC0226 possesses multiple complementary mechanisms supporting intestinal colonization, microbial modulation, and regulation of epithelial junction-associated gene expression, highlighting its potential as a multifunctional probiotic candidate for functional food and nutraceutical applications.
Open AccessA Human-Derived Putative Probiotic, Ligilactobacillus salivarius MCC0226 with Adhesion, Antipathogenic, and Epithelial Gene-Modulatory Properties
Ligilactobacillus salivarius is a well-recognized probiotic species; however, the mechanisms by which individual strains contribute to gut ecosystem homeostasis and protection of the intestinal epithelial barrier remain poorly understood. This study comprehensively characterized a human-derived L. salivarius MCC0226 using an integrated genomic and functional approach to evaluate its probiotic potential. Whole-genome sequencing identified genes associated with acid and bile tolerance, adhesion, exopolysaccharide biosynthesis, oxidative stress response, bacteriocin production, bile salt hydrolase activity, and amino acid biosynthesis. At the same time, genomic safety analysis confirmed the absence of virulence factors and clinically relevant transferable antimicrobial resistance determinants. MCC0226 exhibited high survival under simulated gastric and intestinal conditions, produced 0.64 g L−1 exopolysaccharides, and showed strong adhesion to HT-29 and Caco-2 intestinal epithelial cells. The strain demonstrated broad-spectrum antimicrobial activity against 13 clinically relevant pathogens, reduced adhesion of Salmonella Typhimurium and Clostridioides difficile on HT-29 cells, co-aggregated with enteric pathogens, and produced hydrogen peroxide. Functional metabolite analysis revealed antioxidant activity, cholesterol assimilation under simulated intestinal and colonic conditions, positive bile salt hydrolase activity, and production of lactic, acetic, and butyric acids during inulin fermentation. Furthermore, MCC0226 significantly modulated the expression of epithelial junction-associated genes in HT-29 cells, including OCLN, CLDN3, CDH1, and CLDN2, while ZO-1 remained essentially unaffected. The combined genomic and in vitro evidence indicates that MCC0226 possesses multiple complementary mechanisms supporting intestinal colonization, microbial modulation, and regulation of epithelial junction-associated gene expression, highlighting its potential as a multifunctional probiotic candidate for functional food and nutraceutical applications.
- Open Access
- 27 August 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (9) , 1771
Strain-Dependent Adhesion Variations of Shouchella clausii Isolated from Healthy Human Volunteers: A Study on Cell Surface Properties and Potential Probiotic Benefits
The probiotic potential of Shouchella clausii is widely recognized, but little is known about its adhesive properties. Hence, this study aims to investigate the adhesion potential and cell surface properties of four human-origin S. clausii strains (B619/R, B603/Nb, B106, and B637/Nm). We evaluated epithelial adhesion, Extracellular Matrix (ECM) binding, aggregation ability, and cell surface hydrophobicity and used genome analysis for validation. Our results demonstrate that adhesion capability is a strain-specific attribute, with significant variations observed among the four strains. B619/R, B603/Nb, and B106 displayed stronger adhesion properties than B637/Nm. Supplementary adhesion assays showed that B637/Nm displayed high hydrophobicity, significant auto-aggregation, and significant mucin-binding abilities. Conversely, B619/R, B603/Nb, and B106 had mildly hydrophobic surfaces and low aggregation abilities. Genome annotation revealed the presence of various adhesion proteins in four strains. Notably, the reduced adhesion potential of B637/Nm was supported by the absence of the cell wall surface anchor family protein (LPxTG motif), which is crucial for interactions with intestinal epithelial cells or mucus components. Further, docking studies provided insights into the interaction of adhesion proteins with gut mucins. These findings contribute to a better understanding of how S. clausii strains interact with the gut environment, facilitating the development of probiotic formulations tailored for improved gut health and well-being.
- 27 August 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (9) , 1771
Open AccessStrain-Dependent Adhesion Variations of Shouchella clausii Isolated from Healthy Human Volunteers: A Study on Cell Surface Properties and Potential Probiotic Benefits
The probiotic potential of Shouchella clausii is widely recognized, but little is known about its adhesive properties. Hence, this study aims to investigate the adhesion potential and cell surface properties of four human-origin S. clausii strains (B619/R, B603/Nb, B106, and B637/Nm). We evaluated epithelial adhesion, Extracellular Matrix (ECM) binding, aggregation ability, and cell surface hydrophobicity and used genome analysis for validation. Our results demonstrate that adhesion capability is a strain-specific attribute, with significant variations observed among the four strains. B619/R, B603/Nb, and B106 displayed stronger adhesion properties than B637/Nm. Supplementary adhesion assays showed that B637/Nm displayed high hydrophobicity, significant auto-aggregation, and significant mucin-binding abilities. Conversely, B619/R, B603/Nb, and B106 had mildly hydrophobic surfaces and low aggregation abilities. Genome annotation revealed the presence of various adhesion proteins in four strains. Notably, the reduced adhesion potential of B637/Nm was supported by the absence of the cell wall surface anchor family protein (LPxTG motif), which is crucial for interactions with intestinal epithelial cells or mucus components. Further, docking studies provided insights into the interaction of adhesion proteins with gut mucins. These findings contribute to a better understanding of how S. clausii strains interact with the gut environment, facilitating the development of probiotic formulations tailored for improved gut health and well-being.
- Open Access
- 7 February 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (2) , 347
Unveiling the Probiotic Potential of Streptococcus thermophilus MCC0200: Insights from In Vitro Studies Corroborated with Genome Analysis
Streptococcus thermophilus is widely used as a starter culture in the dairy industry and has garnered attention as a beneficial bacterium owing to its health-promoting functionalities in humans. In this study, the probiotic potential of S. thermophilus MCC0200 isolated from a dairy product was investigated through a combinatorial approach of in vitro and in silico studies. MCC0200 demonstrated the ability to survive harsh gastrointestinal (GI) transit, adhere to intestinal mucosa and exert health-promoting traits in in vitro studies. These findings were corroborated with in silico evidence, wherein, MCC0200 genome harboured genes associated with tolerance to GI conditions, intestinal adhesion and colonization. Genome mapping also highlighted the ability of MCC0200 to produce compounds advantageous for the host (folate, bacteriocins), to release antioxidant enzymes that can quench the free radicals (superoxide dismutase, NADH peroxidase), and to metabolize food components that can be harmful to sensitive people (lactose). MCC0200 also demonstrated a positive effect on reducing cholesterol levels, proving to be a potential candidate for food and pharmaceutical applications. The absence of transmissible antibiotic resistance genes and virulence genes underscored the generally regarded as safe (GRAS) nature of MCC0200. This study explored the potential of Streptococcus thermophilus for its probable applications as a probiotic beyond the dairy industry.
- 7 February 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (2) , 347
Open AccessUnveiling the Probiotic Potential of Streptococcus thermophilus MCC0200: Insights from In Vitro Studies Corroborated with Genome Analysis
Streptococcus thermophilus is widely used as a starter culture in the dairy industry and has garnered attention as a beneficial bacterium owing to its health-promoting functionalities in humans. In this study, the probiotic potential of S. thermophilus MCC0200 isolated from a dairy product was investigated through a combinatorial approach of in vitro and in silico studies. MCC0200 demonstrated the ability to survive harsh gastrointestinal (GI) transit, adhere to intestinal mucosa and exert health-promoting traits in in vitro studies. These findings were corroborated with in silico evidence, wherein, MCC0200 genome harboured genes associated with tolerance to GI conditions, intestinal adhesion and colonization. Genome mapping also highlighted the ability of MCC0200 to produce compounds advantageous for the host (folate, bacteriocins), to release antioxidant enzymes that can quench the free radicals (superoxide dismutase, NADH peroxidase), and to metabolize food components that can be harmful to sensitive people (lactose). MCC0200 also demonstrated a positive effect on reducing cholesterol levels, proving to be a potential candidate for food and pharmaceutical applications. The absence of transmissible antibiotic resistance genes and virulence genes underscored the generally regarded as safe (GRAS) nature of MCC0200. This study explored the potential of Streptococcus thermophilus for its probable applications as a probiotic beyond the dairy industry.
- Open Access
- 7 December 2023
- Published by MDPI AG in Preprints.org
Unveiling the Probiotic Potential of Streptococcus thermophilus MCC0200: Insights from In-vitro Studies corroborated with Genome Analysis
Streptococcus thermophilus is widely used as a starter culture in the dairy industry and has garnered attention as a beneficial bacterium owing to its health-promoting functionalities in humans. In this study, the probiotic potential of S. thermophilus MCC0200, isolated from a dairy product, was investigated through a combinatorial approach of in-vitro and in-silico studies. MCC0200 demonstrated the ability to survive harsh gastro-intestinal transit (GIT), adhere to intestinal mucosa and exert health-promoting traits in in-vitro studies. These findings were corroborated with in-silico evidence, wherein MCC0200 genome harboured genes associated with tolerance to GIT conditions, intestinal adhesion and colonization. Genome mapping also highlighted the ability of MCC0200 to produce compounds advantageous for host (folate, bacteriocins), to release enzymes that can reinforce the host ability (antioxidative enzymes), to metabolize food components that can be harmful to sensitive people (lactose). MCC0200 also demonstrated a positive effect on reducing cholesterol levels, proving to be a potential candidate for food and pharmaceutical applications. Absence of transmissible antibiotic resistance genes and virulence genes underscored the GRAS nature of MCC0200. This study explored the potential of Streptococcus thermophilus for its probable applications as a probiotic beyond the dairy industry.
- 7 December 2023
- Published by MDPI AG in Preprints.org
Open AccessUnveiling the Probiotic Potential of Streptococcus thermophilus MCC0200: Insights from In-vitro Studies corroborated with Genome Analysis
Streptococcus thermophilus is widely used as a starter culture in the dairy industry and has garnered attention as a beneficial bacterium owing to its health-promoting functionalities in humans. In this study, the probiotic potential of S. thermophilus MCC0200, isolated from a dairy product, was investigated through a combinatorial approach of in-vitro and in-silico studies. MCC0200 demonstrated the ability to survive harsh gastro-intestinal transit (GIT), adhere to intestinal mucosa and exert health-promoting traits in in-vitro studies. These findings were corroborated with in-silico evidence, wherein MCC0200 genome harboured genes associated with tolerance to GIT conditions, intestinal adhesion and colonization. Genome mapping also highlighted the ability of MCC0200 to produce compounds advantageous for host (folate, bacteriocins), to release enzymes that can reinforce the host ability (antioxidative enzymes), to metabolize food components that can be harmful to sensitive people (lactose). MCC0200 also demonstrated a positive effect on reducing cholesterol levels, proving to be a potential candidate for food and pharmaceutical applications. Absence of transmissible antibiotic resistance genes and virulence genes underscored the GRAS nature of MCC0200. This study explored the potential of Streptococcus thermophilus for its probable applications as a probiotic beyond the dairy industry.